Follow-Up And Surveillance Of The Patient With Lung Cancer After Curative-Intent Therapy: Diagnosis And Management Of Lung Cancer
Publication Date: May 1, 2013
Last Updated: March 14, 2022
Recommendations
The Role of Imaging Studies
In patients who have undergone curative-intent surgical resection of NSCLC, it is suggested that chest CT be performed every 6 months for the first 2 years after resection and every year thereafter. (2, C)
307795
For patients with NSCLC or carcinoid tumor who have undergone curative-intent therapy, it is recommended that the original treating physicians participate in the decision-making process during the follow-up and surveillance. (1, C)
307795
After curative-intent therapy in patients with NSCLC or carcinoid tumors, routine surveillance with PET imaging, somatostatin receptor scintigraphy (SRS) or abdominal ultrasonography is not recommended. (1, C)
307795
The Role of HRQOL
In NSCLC patients who have undergone curative-intent therapy, it is suggested that a validated HRQOL instrument be used at baseline clinic visits and during follow-up. (2, C)
307795
The Role of Tumor Markers
For lung cancer patients treated with curative intent, it is suggested that surveillance biomarker testing not be done (outside of clinical trials). (2, C)
307795
The Role of Bronchoscopy
For patients with early central airway SqCC treated by curative-intent PDT, it is recommended that surveillance bronchoscopy be done at 1, 2, and 3 months, and thereafter at 3-month intervals during the first year, then every 6 months until 5 years. (1, C)
307795
For patients with intraluminal bronchial carcinoid tumor who have undergone curative-intent bronchoscopic treatment using Nd:YAG or electrocautery, it is suggested that surveillance bronchoscopy be done within 6 weeks after endobronchial resection, every 6 months for 2 years, and annually thereafter. (2, C)
307795
Title
Follow-Up And Surveillance Of The Patient With Lung Cancer After Curative-Intent Therapy: Diagnosis And Management Of Lung Cancer
Authoring Organization
American College of Chest Physicians
Publication Month/Year
May 1, 2013
Last Updated Month/Year
June 26, 2023
External Publication Status
Published
Country of Publication
US
Document Objectives
These guidelines are an update of the evidence-based recommendations for follow-up and surveillance of patients after curative-intent therapy for lung cancer. Particular updates pertain to whether imaging studies, health-related quality-of-life (HRQOL) measures, tumor markers, and bronchoscopy improve outcomes after curative-intent therapy.
Target Patient Population
Patients underwent curative intent therapy for lung cancer
Inclusion Criteria
Female, Male, Adolescent, Adult, Older adult
Health Care Settings
Ambulatory, Hospital, Operating and recovery room, Outpatient, Radiology services
Intended Users
Nurse, nurse practitioner, physician, physician assistant
Scope
Counseling, Assessment and screening, Management
Diseases/Conditions (MeSH)
D018787 - Radiation Oncology, D008175 - Lung Neoplasms, D000073116 - Cancer Survivors, D005500 - Follow-Up Studies, D013902 - Radiography, Thoracic
Keywords
surveillance, lung cancer, follow-up, cancer survivors, counseling
Methodology
Number of Source Documents
94
Literature Search Start Date
June 1, 2005
Literature Search End Date
July 8, 2011